Genome Analysis of Carbapenemase-Negative, Extensively Drug-Resistant Klebsiella pneumoniae Clinical Isolates
- 7 May 2026
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 32 (7) , 271-279
Abstract
Extensively drug-resistant Klebsiella pneumoniae (XDR-KP) poses a major global health threat due to limited treatment options and high mortality. While the genomes of carbapenemase-positive XDR-KP strains are well-documented, there is limited data on carbapenemase-negative XDR-KP. This study characterized the genomes of two such clinical isolates, obtained from abdominal fluid and urine, that were resistant to nearly all tested antibiotics. Antimicrobial susceptibility testing was performed at the Hamilton Regional Microbiology Laboratory, ON. Carbapenemase production and the presence of carbapenemase genes were assessed using the NG-Test ® CARBA-5 and a multiplex carbapenemase PCR assay, respectively. Whole-genome sequencing via Oxford Nanopore technology revealed that both strains lacked carbapenemase genes but harbored multiple other resistance genes ( e.g., bla CTX-M-15 , qnr B1/S1, sul 1/2, dfr A17/A14, fos A) and acr R mutations. Notably, both carried omp K37 mutations, an outer membrane porin previously linked to carbapenem resistance. A number of antibiotic resistance genes were found on conjugative plasmids (IncFIB/IncFII, IncFIA, IncFIA/IncFII). Multilocus sequence typing identified different sequence types (ST307, ST45) and virulence profiling showed overlapping and distinct features, including variability in capsular and siderophore genes. These findings suggest a significant role for porin loss and efflux pump regulation in conferring resistance to broad-spectrum and last-resort antibiotics in clinical XDR-KP isolates that lack carbapenemases and other related antibiotic resistance genes.Keywords
This publication has 31 references indexed in Scilit:
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050The Lancet, 2024
- The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging salmonella strainsGut Microbes, 2024
- Parsnp 2.0: scalable core-genome alignment for massive microbial datasetsBioinformatics, 2024
- Coexistence of blaNDM-5, blaCTX-M-15, blaOXA-232, blaSHV-182 genes in multidrug-resistant K. pneumoniae ST437-carrying OmpK36 and OmpK37 porin mutations: First report in ItalyJournal of Global Antimicrobial Resistance, 2024
- An integrated IncFIB/IncFII plasmid confers hypervirulence and its fitness cost and stabilityEuropean Journal of Clinical Microbiology & Infectious Diseases, 2022
- Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute careJournal of Antimicrobial Chemotherapy, 2020
- How type 1 fimbriae help Escherichia coli to evade extracellular antibioticsScientific Reports, 2016
- Stepwise evolution of pandrug-resistance in Klebsiella pneumoniaeScientific Reports, 2015
- RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogeniesBioinformatics, 2014
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesThe Lancet Infectious Diseases, 2013